ORGANOGENESIS HOLDINGS INC. Investment Income, Interest
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Investment Income, Interest of $19.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2019-05-10
- ORGANOGENESIS HOLDINGS INC. investment income, interest for the quarter ending 2019-03-31 was $19.00K, a 0.00% change year-over-year.
- ORGANOGENESIS HOLDINGS INC. investment income, interest for the quarter ending 2018-12-31 was $5.00K, a 82.14% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. investment income, interest for the quarter ending 2018-09-30 was $20.00K, a 28.57% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. investment income, interest for the quarter ending 2018-06-30 was $20.00K, a 42.86% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. investment income, interest for fiscal 2018 was $64.00K, a 50.39% decline from fiscal 2017.
- ORGANOGENESIS HOLDINGS INC. investment income, interest for fiscal 2017 was $129.00K, a 15.69% decline from fiscal 2016.
- ORGANOGENESIS HOLDINGS INC. investment income, interest for fiscal 2016 was $153.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-03-31 | $19.00K 10-Q · filed 2019-05-10 | $24.00K derived: sum of 2 quarters · filed 2019-05-10 | $44.00K derived: sum of 3 quarters · filed 2019-05-10 | $64.00K derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2018-12-31 | $5.00K 10-K · filed 2019-03-18 | $25.00K derived: sum of 2 quarters · filed 2019-03-18 | $45.00K derived: sum of 3 quarters · filed 2019-03-18 | $64.00K 10-K · filed 2019-03-18 | ||
| 2018-09-30 | $20.00K 10-K · filed 2019-03-18 | $1.46M 10-Q · filed 2018-11-09 | $40.00K derived: sum of 2 quarters · filed 2019-03-18 | $3.79M 10-Q · filed 2018-11-09 | $87.00K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-06-30 | $20.00K 10-K · filed 2019-03-18 | $1.30M 10-Q · filed 2018-08-07 | $2.32M 10-Q · filed 2018-08-07 | $67.00K derived: sum of 3 quarters · filed 2019-05-10 | $95.00K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-03-31 | $19.00K 10-Q · filed 2019-05-10 | $1.02M 10-Q · filed 2018-05-10 | $47.00K derived: sum of 2 quarters · filed 2019-05-10 | $75.00K derived: sum of 3 quarters · filed 2019-05-10 | $110.00K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $28.00K 10-K · filed 2019-03-18 | $56.00K derived: sum of 2 quarters · filed 2019-03-18 | $91.00K derived: sum of 3 quarters · filed 2019-03-18 | $129.00K 10-K · filed 2019-03-18 | $2.50M 10-K · filed 2018-03-14 | |
| 2017-09-30 | $28.00K 10-K · filed 2019-03-18 | $736.13K 10-Q · filed 2017-11-14 | $63.00K derived: sum of 2 quarters · filed 2019-03-18 | $1.70M 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $35.00K 10-K · filed 2019-03-18 | $602.14K 10-Q · filed 2017-08-11 | $961.65K 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | $38.00K 10-K · filed 2019-03-18 | $359.51K 10-Q · filed 2017-05-12 | ||||
| 2016-12-31 | $153.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |